How should investors evaluate Humacyte Inc (NASDAQ:HUMA)?

Stocks of Humacyte Inc (NASDAQ:HUMA) traded higher last session on Wall Street, down -1.17% to $2.54. HUMA stock price is now 18.70% away from the 50-day moving average and -29.35% away from the 200-day moving average. The market capitalization of the company currently stands at $394.00M. On December 20, 2024, H.C. Wainwright reiterated its ‘Buy’ […]

Do investors have a safe investment in EQT Corp (NYSE:EQT)?

The price of EQT Corp (NYSE:EQT) shares last traded on Wall Street rose 0.04% to $54.88. EQT stock price is now -1.37% away from the 50-day moving average and 13.54% away from the 200-day moving average. The market capitalization of the company currently stands at $34.24B. On July 07, 2025, Barclays recently initiated its ‘Overweight’ […]

Do you still think Western Digital Corp (NASDAQ:WDC) is worth a look?

In Wednesday’s Wall Street session, Western Digital Corp (NASDAQ:WDC) shares traded at $64.64, up 0.97% from the previous session. WDC stock price is now 20.12% away from the 50-day moving average and 31.77% away from the 200-day moving average. The market capitalization of the company currently stands at $22.55B. On May 01, 2025, TD Cowen […]

Reasons why StoneCo Ltd’s (NASDAQ:STNE) fundamentals are futile

In Wednesday’s Wall Street session, StoneCo Ltd (NASDAQ:STNE) shares traded at $16.63, up 1.96% from the previous session. STNE stock price is now 16.55% away from the 50-day moving average and 49.19% away from the 200-day moving average. The market capitalization of the company currently stands at $4.52B. On September 05, 2024, Morgan Stanley Downgraded […]

A breakdown of the latest mutual funds holding GE Aerospace (GE)

Stocks of GE Aerospace (NYSE:GE) traded higher last session on Wall Street, up 1.33% to $250.33. GE stock price is now 6.50% away from the 50-day moving average and 25.74% away from the 200-day moving average. The market capitalization of the company currently stands at $266.95B. On April 09, 2025, Northcoast Upgraded its previous ‘Neutral’ […]

An overview of Prime Medicine Inc’s (PRME) institutional holdings

The price of Prime Medicine Inc (NASDAQ:PRME) shares last traded on Wall Street rose 10.73% to $4.54. PRME stock price is now 150.36% away from the 50-day moving average and 73.38% away from the 200-day moving average. The market capitalization of the company currently stands at $596.08M. With the price target maintained at $1.50, Citigroup […]

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.